APA (7th ed.) Citation

Umeda, Y., Kimura, S., Kimura, J., Imamura, Y., & Ishizuka, T. Tepotinib for the Treatment of Lung Adenocarcinoma Harboring MET Y1003N Point Mutation: A Case Report. Wiley.

Chicago Style (17th ed.) Citation

Umeda, Yukihiro, Satomi Kimura, Junya Kimura, Yoshiaki Imamura, and Tamotsu Ishizuka. Tepotinib for the Treatment of Lung Adenocarcinoma Harboring MET Y1003N Point Mutation: A Case Report. Wiley.

MLA (9th ed.) Citation

Umeda, Yukihiro, et al. Tepotinib for the Treatment of Lung Adenocarcinoma Harboring MET Y1003N Point Mutation: A Case Report. Wiley.